Scientific Sessions & Networking

The event included various scientific sessions that delved into topics such as complement biology, disease mechanisms, and novel therapeutic strategies. Early-career researchers had the opportunity to present their work through poster sessions, fostering collaboration and networking.

During the scientific sessions at EMCHD 2024, several key insights were gained that highlighted the latest advancements in complement research:

• Complement Biology & Disease Mechanisms: Researchers presented new findings on the intricate roles of complement proteins in various diseases, including autoimmune disorders and infectious diseases. These insights are crucial for understanding how complement dysregulation contributes to disease pathology.
• Novel Therapeutic Strategies: There was a strong focus on translating basic scientific discoveries into therapeutic applications. Innovative approaches, such as complement inhibitors and targeted therapies, were discussed, showcasing their potential in treating conditions like age-related macular degeneration and atypical hemolytic uremic syndrome.
• Complement & Cancer: One of the sessions explored the complex role of the complement system within the tumor microenvironment. Researchers shared data on how complement activation can influence tumor growth and metastasis, opening new avenues for cancer treatment.
• Emerging Technologies: The conference also highlighted the use of cutting-edge technologies, such as CRISPR and advanced imaging techniques, to study complement pathways. These technologies are enabling more precise and comprehensive analyses, leading to better-targeted therapies.
• Clinical Applications: Several presentations focused on the clinical applications of complement research. Case studies and clinical trials were discussed, demonstrating the real-world impact of complement-targeted therapies on patient outcomes.

Celebrating Complement Excellence

Another notable highlight was the lunch seminar on the second day, followed by the much-awaited announcement and prize ceremony for the Svar Complement Excellence Award. The award ceremony was a significant moment, celebrating the recipients of the 2024 Svar Complement Excellence Award. The selection process was highly competitive, with numerous high-quality applications. This year, the award was presented to Dr. Elena Goicoechea de Jorge and Dr. Sophie Chauvet for their important complement research. We look forward to sharing more about the innovative work of the award winners and exciting developments ahead.

With EMCHD 2024 now concluded, we extend our sincere gratitude to the ECN and the organizing committee for their exceptional efforts. The contributions from all speakers and poster presenters were invaluable, inspiring continued exploration and innovation in the complement field. This event provided a platform for knowledge exchange and collaboration among experts, leaving participants with a deeper understanding of the complement system and its potential to combat human diseases.

As an expert in the complement system, Svar harnesses years of experience and deep specialist knowledge in innate immunity, the complement system, and its intricate connections. Our synergetic platforms deliver tailored solutions spanning immunoassay development, cell engineering, and contract research services that address our customers’ assessment and testing needs. We anticipate continued progress and collaboration in the field of complement.